Researchers Develop Innovative Catheter for Targeted Brain Drug Delivery

Researchers at New York University Abu Dhabi have introduced a novel catheter designed to enhance drug delivery to various regions of the brain. This innovative device, named the Strategic Precision Infusion for Regional Administration of Liquid (SPIRAL), features a helical structure with multiple outflow ports, potentially improving treatment efficacy for neurological disorders such as Parkinson’s disease, epilepsy, and brain tumors.

Current methods for delivering drugs to the brain often involve implanting microfluidic catheters that provide controlled doses of medication to highly localized areas. These catheters are made from flexible materials that closely mimic brain tissue, significantly reducing invasiveness compared to earlier designs. Despite these advancements, challenges remain in achieving optimal drug distribution. As lead researcher Batoul Khlaifat notes, “Catheter design and function have long been limited by the neuroinflammatory response after implantation, as well as the unequal drug distribution across the catheter’s outlets.”

One of the primary issues with existing catheters is their inability to effectively target the brain’s irregularly shaped regions. This limitation often necessitates multiple insertions or the use of several co-implanted catheters, increasing the risk of trauma. To address these concerns, Khlaifat and her team investigated how the design of catheters impacts drug delivery efficiency. Traditional designs typically consist of simple tubes with single input and output ports, which can lead to uneven drug flow.

Using fluid dynamics simulations, the researchers examined how repositioning multiple output ports along the catheter’s length could improve drug distribution. By adjusting the diameter of these ports, they ensured that each port could deliver approximately one quarter of the total flow evenly. This innovative approach laid the groundwork for further enhancements in catheter design.

Advancements in Catheter Design

The research team then explored how altering the catheter’s shape could further optimize drug delivery. They transitioned from a straight catheter design to a helical configuration, which allows for a larger area of drug distribution within the targeted region while minimizing invasiveness. Team member Khalil Ramadi explained, “This helical shape also allows us to resist buckling on insertion, which is a major problem for miniaturized straight catheters.”

After developing the SPIRAL catheter, the team conducted experiments in controlled laboratory settings to validate their simulations. They confirmed that their design achieved even outflow rates across the catheter’s outlets. Additionally, they tested the neuroinflammatory response of the helical device against its straight counterpart in mouse models, finding no significant differences between the two designs.

With the safety of the SPIRAL catheter established, the researchers are optimistic about its potential to transform targeted drug delivery in neurology. The ability to administer smaller, controlled doses to entire brain regions could enhance the effectiveness of treatments for various neurological conditions. Mahmoud Elbeh, another team member, highlighted the personalized aspect of this technology, stating, “These catheters could be optimized for each patient through our computational framework to ensure only regions that require dosing are exposed to therapy, all through a single insertion point in the skull.”

The findings of this research are published in the Journal of Neural Engineering. As scientists continue to explore innovative solutions for brain disorders, the SPIRAL catheter represents a significant advancement that could ultimately improve patient outcomes and treatment methodologies in the field of neurology.